Identification of a novel homozygous synthesis of cytochrome c oxidase 2 variant in siblings with early-onset axonal Charcot-Marie-Tooth disease.
Andrea GangfußAndreas HentschelNina RademacherAlbert SickmannBurkhard StüveRita HorvathClaudia GrossNicolai KohlschmidtFabian FörsterAngela AbichtAnne SchänzerUlrike Schara-SchmidtAndreas RoosAdela Della MarinaPublished in: Human mutation (2022)
The synthesis of cytochrome c oxidase 2 (SCO 2 ) gene encodes for a mitochondrial located metallochaperone essential for the synthesis of the cytochrome c oxidase (COX) subunit 2. Recessive mutations in SCO 2 have been reported in several cases with fatal infantile cardioencephalomyopathy with COX deficiency and in only four cases with axonal neuropathy. Here, we identified a homozygous pathogenic variant (c.361G > C; p.[Gly121Arg]) in SCO 2 in two brothers with isolated axonal motor neuropathy. To address pathogenicity of the amino acid substitution, biochemical studies were performed and revealed increased level of the mutant SCO 2 -protein and dysregulation of COX subunits in leukocytes and moreover unraveled decrease of proteins involved in the manifestation of neuropathies. Hence, our combined data strengthen the concept of SCO 2 being causative for a very rare form of axonal neuropathy, expand its molecular genetic spectrum and provide first biochemical insights into the underlying pathophysiology.
Keyphrases
- early onset
- spinal cord injury
- amino acid
- late onset
- optic nerve
- genome wide
- copy number
- oxidative stress
- single cell
- machine learning
- electronic health record
- big data
- gene expression
- escherichia coli
- biofilm formation
- staphylococcus aureus
- peripheral blood
- pseudomonas aeruginosa
- cystic fibrosis
- binding protein
- muscular dystrophy